Bausch + Lomb Gains CE Mark for SeeLyra Femtosecond Laser
VAUGHAN, Ontario — September 11, 2026 Bausch + Lomb Corporation announced that its next-generation SeeLyra™ femtosecond laser has received...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
VAUGHAN, Ontario — September 11, 2026 Bausch + Lomb Corporation announced that its next-generation SeeLyra™ femtosecond laser has received...
Irvine, Calif., July 27, 2026 Masimo, a Danaher company and global leader in patient monitoring technologies, has received U.S....
PITTSBURGH, Pa., April 17, 2026 Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k)...
